Home / Stocks / VKTX

VKTX insider trading

Viking Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
3
Bought · 24 mo
$210k
Buys · last 90 days
0 · $0
Most recent buy
2026-03-10

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-07-29Lian Brian
President & CEO
Sold148,517$33.32$4.9M
2026-03-10Aubuchon Neil William
Chief Commercial Officer
Bought4,475$33.50$150k
2026-01-05ZANTE GREG
Chief Financial Officer
Sold31,961$32.30$1.0M
2026-01-05Mancini Marianna
Chief Operating Officer
Sold31,961$32.29$1.0M
2026-01-05Lian Brian
President & CEO
Sold227,009$32.90$7.5M
2025-10-28Rowland Charles A Jr
Director
Sold60,000$35.57$2.1M
2025-10-28Lian Brian
President & CEO
Sold38,989$35.01$1.4M
2025-04-08Rouan Sarah Kathryn
Director
Bought1,240$24.15$30k
2025-04-02Rouan Sarah Kathryn
Director
Bought1,240$24.15$30k
2025-01-06Lian Brian
President & CEO
Sold175,490$42.68$7.5M
2025-01-06Mancini Marianna
Chief Operating Officer
Sold49,115$42.69$2.1M
2025-01-06ZANTE GREG
Chief Financial Officer
Sold45,609$42.69$1.9M
2024-10-28ZANTE GREG
Chief Financial Officer
Sold107,199$76.06$8.2M
2024-10-25SINGLETON J MATTHEW
Director
Sold16,000$79.50$1.3M
2024-09-20Lian Brian
President & CEO
Sold215,930$70.83$15.3M

Most active insider buyers

InsiderRoleBuysTotal bought
Aubuchon Neil WilliamChief Commercial Officer1$150k
Rouan Sarah KathrynDirector2$60k

See VKTX on the chart

Every insider buy and sell for VKTX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.